GC
Hansoh Pharma, Hongqiao tap Asia CB market
Hong Kong-listed Hansoh Pharmaceutical Group and China Hongqiao Group have added to the burst of convertible bond activity in the first week of 2021, raising a combined $900m from the equity-linked market on Thursday.
The duo came alongside Taiwan’s Win Semiconductors Corp, which printed a $500m negative yielding CB, the fourth deal in Asia’s equity-linked market this week. The three Thursday trades followed a €230m CB from Zhejiang Expressway on Tuesday.
“What I found interesting [on Thursday] night was how ...Already a subscriber? Login
